Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00494936 · ClinicalTrials.gov registry record

Effects of HIV and Hepatitis C Virus on the Brain

A clinical trial, sponsored by Icahn School of Medicine at Mount Sinai.

Completed
Registry status
78
Enrollment target

NCT00494936: Completed study, sponsored by Icahn School of Medicine at Mount Sinai.

NCT00494936 is a clinical trial that has completed, run by Icahn School of Medicine at Mount Sinai. The registered enrollment target is 78 participants. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00494936 has completed, sponsored by Icahn School of Medicine at Mount Sinai.

COMPLETED
Registry status
78 participants
Enrollment target

Study Summary

This study will determine the effects that HIV and hepatitis C virus have on thinking abilities and whether the viruses affect brain chemistry.

Trial Details

FieldValue
Enrollment Target 78 participants
Start Date 2006-05
Est. Completion 2009-07

What the finished NCT00494936 record still lists

NCT00494936 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 78 participants, a relatively small participant target.

The record links to 0 conditions, and to 0 interventions.

NCT00494936 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT00494936 about?

NCT00494936 is a clinical study titled "Effects of HIV and Hepatitis C Virus on the Brain". This study will determine the effects that HIV and hepatitis C virus have on thinking abilities and whether the viruses affect brain chemistry.

What is the current status of trial NCT00494936?

This trial is currently completed. The enrollment target is 78 participants. The study started on 2006-05. Estimated completion is 2009-07.

Who is sponsoring clinical trial NCT00494936?

This trial is sponsored by Icahn School of Medicine at Mount Sinai, which has 708 total clinical trials registered on ClinicalTrials.gov.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02397668 · 78 participants · NA

    CorMatrix Cor TRICUSPID ECM Valve Replacement Study

  • NCT03321656 · 78 participants · Phase 2

    Impact of Envarsus XR® on Kidney Biopsy Subclinical Rejection and Blood Immunologic Profile

  • NCT03687814 · 78 participants · NA

    Low FODMAP Plus PEG 3350 for the Treatment of Patients with Irritable Bowel Syndrome-Constipation

  • NCT04018872 · 78 participants · Phase 2

    Evaluating the Effect of Itraconazole on Pathologic Complete Response Rates in Esophageal Cancer

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT00494936, the US trial registry maintained by the National Library of Medicine. NCT00494936 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.